Ginette S Santiago-Sanchez (Ginette Santiago-Sánchez, Ginette S Santiago-Sánchez)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Papillary Thyroid

Top Venues

Cancer biology & therapy

Cancer immunology, immunotherapy : CII

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ginette S Santiago-Sanchez, Kellsye P Fabian, James W Hodge
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance. Cancer biology & therapy 25 (1) (2024)
Ginette S Santiago-Sanchez, Kellsye P Fabian, James W Hodge
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance. Cancer biology & therapy 25 (1) (2024)
Ginette S Santiago-Sanchez, Kellsye P Fabian, James W Hodge
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance. Cancer biology & therapy 25 (1) (2024)
Ginette S Santiago-Sanchez, Kellsye P Fabian, James W Hodge
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance. Cancer biology & therapy 25 (1) (2024)
Ginette S Santiago-Sanchez, Kellsye P Fabian, James W Hodge
A landscape of checkpoint blockade resistance in cancer: underlying mechanisms and current strategies to overcome resistance. Cancer biology & therapy 25 (1) (2024)
S Elizabeth Franks, Ginette S Santiago-Sanchez, Kellsye P Fabian, Kristen Solocinski, Paul L Chariou, Duane H Hamilton, Joshua T Kowalczyk, Michelle R Padget, Sofia R Gameiro, Jeffrey Schlom, James W Hodge
Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer immunology, immunotherapy : CII (2023)
Robert J Rabelo-Fernández, Ginette S Santiago-Sanchez, Rohit K Sharma, Abiel Roche-Lima, Kelvin Carrasquillo Carrion, Ricardo A Noriega Rivera, Blanca I Quiñones-Díaz, Swetha Rajasekaran, Jalal Siddiqui, Wayne O Miles, Yasmarie Santana Rivera, Fatima Valiyeva, Pablo E Vivas-Mejía
Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells. International journal of molecular sciences 23 (1) (2022)
S Elizabeth Franks, Kellsye P Fabian, Ginette S Santiago-Sanchez, Benjamin Wolfson, James W Hodge
Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGFβ) provides significant antitumor efficacy in immune checkpoint resistant models. Oncoimmunology 11 (1) (2022)